Bio-Techne
TECH
#2033
Rank
ยฃ5.52 B
Marketcap
ยฃ34.97
Share price
-2.57%
Change (1 day)
-31.12%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of December 2024 : ยฃ0.29 Billion

According to Bio-Techne's latest financial reports the company's total debt is ยฃ0.29 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2024-06-30ยฃ0.33 B-8.06%
2023-06-30ยฃ0.36 B34.23%
2022-06-30ยฃ0.26 B-11.56%
2021-06-30ยฃ0.30 B-13.73%
2020-06-30ยฃ0.35 B-11.5%
2019-06-30ยฃ0.39 B55.05%
2018-06-30ยฃ0.25 B-2.86%
2017-06-30ยฃ0.26 B273.49%
2016-06-30ยฃ70.74 M44.49%
2015-06-30ยฃ48.96 M544.21%
2014-06-30ยฃ7.6 M
2006-06-30ยฃ7.26 M-11.05%
2005-06-30ยฃ8.16 M-6.29%
2004-06-30ยฃ8.71 M-15.94%
2003-06-30ยฃ10.36 M-12%
2002-06-30ยฃ11.77 M-11.97%
2001-06-30ยฃ13.37 M2.41%
2000-06-30ยฃ13.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ23.33 B 7,815.18%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.02 B 247.91%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ13.99 B 4,647.33%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.79 B 4,239.36%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.05 B 258.34%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ14.38 B 4,777.67%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.34 M-99.21%๐Ÿ‡บ๐Ÿ‡ธ USA